If You have any Questions ask us here! -OR-Call 13 Face (13 32 23)
 
  •  

    Injectables vs. a cosmetic snip

    Are nip and tuck procedures losing their allure? Could consumers be abandoning cosmetic nip and tuck surgical procedures in droves, seeking rejuvenating injectable treatments instead? Whether it’s a long-term trend or a temporary consumer response to difficult economic times, the reality is that a lot of people are delaying surgery. Instead, they are turning to less costly and more convenient non-surgical options such as injectables.

    The American Society for Aesthetic Plastic Surgery reports that according to two surveys from 2011—one among potential consumers and the other among physician members of ASAPS—the vast majority of patients placed a higher priority on the duration of effect over cost when selecting medical anti-ageing treatments. Surprisingly—and contradictory—their physicians thought that patients were seeking immediate effects and valued cost over relatively longer-lasting results. The full results of the surveys were published in the September 2011 issue of the Aesthetic Surgery Journal.

    According to the leading author, T. Jonathan Kurkjian, MD, of the University of Texas Southwestern Medical Center, how the economy was affecting patients’ choices was no surprise to him. He says that previous ASAPS surveys have shown “a decrease in aesthetic surgical procedures and a slight increase in nonsurgical procedures over recent years.”

    What were patients turning to instead? According to the study, they were preceding nip and tuck facial surgeries such as facelifts, eyelid surgery, and facial implants and opting for the less costly non-surgical options such as anti-wrinkle injections, fillers, and chemical peels.

    Statistics of cosmetic surgical and non-surgical procedures from the American Society of Plastic Surgeons indicate that these observations are not merely a short term trend. Although nip and tuck surgical procedures showed a meager growth of 2 percent between 2010 and 2011, comparing figures of 2000 with those of 2011 highlights an overall downward trend; a decline of 17 percent over the 11 year period from 2000.

    Of the U.S. top five nip and tuck procedures in 2011, the most popular, breast augmentation, grew by 4 percent over the previous year. Over the same period, the number of facelifts and liposuction procedures increased by 5 % and 1 % respectively, and the number of eyelid surgeries and nose reshaping procedures dropped by 6 % and 3 % respectively. All the top five procedures with the exception of breast augmentation show double-digit negative growth in 2011 when compared with their 2000 figures. Breast augmentation increased by 45 percent during this period.

    Minimally invasive procedures, led by anti-wrinkle toxin injections and soft tissue fillers, more than doubled (123%) between 2000 and 2011 from 7.4 million procedures to 13.8 million. The corresponding 2010 figure is 13.1 million procedures, giving rise to a 2011 year on year growth rate of 5 percent.

    These numbers are a clear indication of the direction in which U.S. consumer tastes and preferences are moving; and as the consumers themselves say, it is not all about costs.

    Injectables – soft tissue fillers and anti-wrinkle—now possess the top two spots on the top five minimally invasive cosmetic procedures list in the United States, the largest aesthetic medicine market in the entire world.

    The number of injectables in the U.S. grew by 5 percent from 2010 levels to reach nearly 5.8 million procedures by the end of 2011. Their growth rate between 2000 and 2011 was an astonishing 621 percent. Soft tissue fillers grew by 7 percent from 2010 figures, and by 190 percent from 2000 figures to reach nearly 1.9 million procedures in 2011.

    The massive increase of injectables can also be attributed to the introduction of brand kinds of soft tissue fillers. The U.S. 2000 statistics quoted above only contain figures for fat and collagen injections under the soft tissue fillers category. Now fat and collagen account for only around 7 percent of the nearly 1.9 million injectable treatments.

    Although we do not have comparable statistics on hand for Australia, an April 2012 media release from the Cosmetic Physicians Society of Australasia (CPSA) indicates that the same trend applies here as well, even to a larger degree than in the U.S.

    Says Dr. Gabrielle Caswell, the President of the CPSA: “The demand for non-surgical cosmetic treatments continues to grow for a number of reasons, but one of the primary factors is new developments in this evolving area of medicine. Emerging treatments are less invasive, more efficient and less expensive, making them more appealing and accessible to patients.”

    According to the CPSA, which started estimating the value of the non-surgical cosmetic industry beginning with 2008, there have been five consecutive years of growth in the amount that Australians spend on non-surgical cosmetic treatments. During this period, the spending more than doubled from an estimated $300 million in 2008 to $644.7 million by 2012. The year on year growth for the last year is expected to be around 15 percent.

    CPSA doctors say that the most popular procedures in Australia continue to be anti-wrinkle treatments including muscle relaxants (anti-wrinkle injections) and cosmetic dermal fillers.

    From a recent survey conducted with Merz, we learned that Australians simply love injectables and see no problem in making it the next lipstick. Women who are likely or current users say that they’d sacrifice a lot to be able to afford injectable treatments.

    Translate »